Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Clearline Capital LP

Clearline Capital LP decreased its stake in Teladoc Health, Inc. (NYSE:TDOC) by 88.1% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 519,340 shares of the health services provider’s stock after selling 3,844,861 shares during the quarter. Clearline Capital LP owned 0.30% of Teladoc Health worth $4,768,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Rubric Capital Management LP acquired a new position in shares of Teladoc Health in the second quarter worth about $45,267,000. Point72 Asset Management L.P. boosted its stake in Teladoc Health by 221.9% in the 2nd quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider’s stock worth $51,865,000 after purchasing an additional 3,655,436 shares during the period. Assenagon Asset Management S.A. purchased a new position in Teladoc Health during the 3rd quarter worth approximately $15,801,000. Mizuho Markets Americas LLC acquired a new stake in Teladoc Health during the 2nd quarter valued at $3,937,000. Finally, Robeco Institutional Asset Management B.V. lifted its stake in Teladoc Health by 141.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 575,055 shares of the health services provider’s stock worth $5,279,000 after acquiring an additional 337,305 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on TDOC shares. Barclays upped their target price on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Evercore ISI boosted their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. TD Cowen cut their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Jefferies Financial Group boosted their target price on Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a research note on Tuesday, September 17th. Finally, The Goldman Sachs Group initiated coverage on Teladoc Health in a research note on Friday, November 15th. They set a “buy” rating and a $14.00 price target for the company. Fourteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Teladoc Health currently has a consensus rating of “Hold” and a consensus price target of $12.08.

Insider Activity

In other Teladoc Health news, CFO Mala Murthy sold 8,750 shares of Teladoc Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the sale, the chief financial officer now owns 85,767 shares in the company, valued at $614,091.72. The trade was a 9.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Thomas Mckinley bought 4,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the purchase, the director now owns 39,077 shares of the company’s stock, valued at $300,502.13. This trade represents a 11.40 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 20,051 shares of company stock valued at $143,565. Insiders own 0.95% of the company’s stock.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $11.98 on Monday. The company has a market cap of $2.06 billion, a price-to-earnings ratio of -2.08 and a beta of 0.90. The business has a 50 day moving average price of $9.38 and a 200 day moving average price of $9.25. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $22.54.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. The business had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.